Author Archives: Guest Post

Researchers Uncover How New Melanoma Drug Accelerates Secondary Skin Cancers

Patients with metastatic melanoma taking the recently approved drug vemurafenib (marketed as Zelboraf) responded well to the twice-daily pill, but some of them developed a different, secondary skin cancer.

Now, researchers at UCLA’s Jonsson Comprehensive Cancer Center, working with investigators from the Institute of Cancer Research in London, Roche and Plexxikon, have elucidated the mechanism by which the drug excels at fighting melanoma but also allows for the development of skin squamous-cell carcinomas. (more…)

Read More

Solving The Mystery of An Old Drug That May Reduce Cancer Risk

In 2005, news first broke that researchers in Scotland found unexpectedly low rates of cancer among diabetics taking metformin, a drug commonly prescribed to patients with Type II diabetes. Many follow-up studies reported similar findings, some suggesting as much as a 50-per-cent reduction in risk. How could this anti-diabetic drug reduce the risk of developing cancer and what were the mechanisms involved? (more…)

Read More

Yahoo! to Offer Exclusive Coverage of 2012 Sundance Film Festival, Including Select Short Films Streaming Free Online

First-Ever Online “Audience Award” Enables Fans to Vote for Best Short Film on Yahoo! Screen

Yahoo! Movies & omg! NOW Feature Behind-The-Scenes Content Straight from Park City

SUNNYVALE, Calif. — Yahoo!, the premier digital media company, is opening the doors to the 2012 Sundance Film Festival, giving independent film fans access to one of the year’s most highly anticipated industry events. The general public will have access to 9 short films from this year’s Festival by visiting sundance.yahoo.com, powered by Yahoo! Screen, Yahoo’s video destination and home to the most comprehensive collection of premium video content. (more…)

Read More